Product

YCT-529

Aliases

YCT-529 Placebo

1 clinical trial

1 indication

Indication

Male Contraception

Clinical trial

Double-blind, Placebo Controlled, First in Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of YCT-529

Status: Recruiting, Estimated PCD: 2024-06-01